Rhelion confirms further PEX010 delivery to Germany compassionate use program
Rhelion Life Sciences said it has confirmed further delivery of Filament Health's PEX010 to Germany’s First Psilocybin Compassionate Use Program.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.